FDA Inspection
Michael P. Husseman, MDMichael P. Husseman, MD – FDA Inspection, Dec 23, 2014
Record Details
This FDA Inspection record concerns Michael P. Husseman, MD, with an inspection on December 23, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Michael P. Husseman, MD
- Inspection Date
- December 23, 2014
- Product Type
- Biologics
View Company Profile
ID · 0a0ea788-7887-45e3-a9ec-8d65c2b731c8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 910840
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael P. Husseman, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2022 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| February 16, 2010 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael P. Husseman, MD
- FDA Inspection 1164828 - 2022-02-18
- FDA Inspection 644316 - 2010-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.